Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)

Affiliation auteurs!!!! Error affiliation !!!!
TitreNeoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)
Type de publicationJournal Article
Year of Publication2020
AuteursWislez M., Mazieres J., Lavole A., Zalcman G., Carre O., Egenod T., Caliandro R., Gervais R., Jeannin G., Molinier O., Massiani M.A, Langlais A., Morin F., F. Barthes LPimpec, Brouchet L., Assouad J., Milleron B., Damotte D., Antoine M., Westeel V.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS794
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.1416